Home/Holobiome/Kim Lewis, PhD

KL

Kim Lewis, PhD

Co-founder, Director, Scientific Advisor

Therapeutic Areas

Neurological Disorders Psychiatric Disorders Gastrointestinal Diseases Metabolic Disorders

Holobiome Pipeline

Drug	Indication	Phase
Undisclosed	Neurological/Psychiatric Disorders (e.g., via gut-brain axis)	Preclinical

Leadership Team at Holobiome

Philip Strandwitz, PhD

Co-founder, CEO

Mike La Fleur, PhD, MBA

Co-founder, President

Gabe Al-Ghalith, PhD

VP of Computational Biology

Iain Chessell, PhD

Director (Board), VP & Head of Neuroscience, AstraZeneca

View full Holobiome profile